Cochrane Abstracts
Oral and intranasal aspirin desensitisation for non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral and Intranasal Aspirin Desensitisation for Non‐steroidal Anti‐inflammatory Drug (NSAID)‐exacerbated Respiratory Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435968/all/Oral_and_intranasal_aspirin_desensitisation_for_non‐steroidal_anti‐inflammatory_drug__NSAID_‐exacerbated_respiratory_disease.
Oral and intranasal aspirin desensitisation for non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435968/all/Oral_and_intranasal_aspirin_desensitisation_for_non‐steroidal_anti‐inflammatory_drug__NSAID_‐exacerbated_respiratory_disease. Accessed January 20, 2025.
Oral and intranasal aspirin desensitisation for non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435968/all/Oral_and_intranasal_aspirin_desensitisation_for_non‐steroidal_anti‐inflammatory_drug__NSAID_‐exacerbated_respiratory_disease
Oral and Intranasal Aspirin Desensitisation for Non‐steroidal Anti‐inflammatory Drug (NSAID)‐exacerbated Respiratory Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435968/all/Oral_and_intranasal_aspirin_desensitisation_for_non‐steroidal_anti‐inflammatory_drug__NSAID_‐exacerbated_respiratory_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral and intranasal aspirin desensitisation for non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease
ID - 435968
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435968/all/Oral_and_intranasal_aspirin_desensitisation_for_non‐steroidal_anti‐inflammatory_drug__NSAID_‐exacerbated_respiratory_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
